Found: 9
Select item for more details and to access through your institution.
Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 103, doi. 10.1111/j.1476-5829.2010.00211.x
- By:
- Publication type:
- Article
Acanthomatous ameloblastoma in dogs treated with intralesional bleomycin.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 81, doi. 10.1111/j.1476-5829.2010.00208.x
- By:
- Publication type:
- Article
Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 112, doi. 10.1111/j.1476-5829.2010.00210.x
- By:
- Publication type:
- Article
Expression of the high mobility group A1 ( HMGA1) and A2 ( HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 87, doi. 10.1111/j.1476-5829.2010.00207.x
- By:
- Publication type:
- Article
Abstracts presented at the 29th Annual VCS Conference, Austin, TX, USA, 16–19 October 2009.
- Published in:
- 2010
- Publication type:
- Abstract
Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 96, doi. 10.1111/j.1476-5829.2010.00209.x
- By:
- Publication type:
- Article
Cystosonographic measurements of canine bladder tumours.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 122, doi. 10.1111/j.1476-5829.2010.00212.x
- By:
- Publication type:
- Article
High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 127, doi. 10.1111/j.1476-5829.2010.00216.x
- By:
- Publication type:
- Article
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 138, doi. 10.1111/j.1476-5829.2010.00217.x
- By:
- Publication type:
- Article